Secondary prevention of stroke: Can we do better than aspirin?

Dharam J. Kumbhani; Deepak L. Bhatt

doi:10.1016/S1474-4422(10)70217-9

Secondary prevention of stroke: Can we do better than aspirin?

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	942-943
Number of pages	2
Journal	The Lancet Neurology
Volume	9
Issue number	10
DOIs	https://doi.org/10.1016/S1474-4422(10)70217-9
State	Published - Oct 2010

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1016/S1474-4422(10)70217-9

Cite this

@article{5f4d36068da04d12b6a9ca620be3943a,

title = "Secondary prevention of stroke: Can we do better than aspirin?",

author = "Kumbhani, {Dharam J.} and Bhatt, {Deepak L.}",

note = "Funding Information: DJK has no conflicts of interest. DLB has received institutional research support from AstraZeneca, Bristol-Myers Squibb, Eisai, Sanofi-Aventis, and The Medicines Company and has received honoraria from Duke Clinical Research Institute.",

year = "2010",

month = oct,

doi = "10.1016/S1474-4422(10)70217-9",

language = "English (US)",

volume = "9",

pages = "942--943",

journal = "The Lancet Neurology",

issn = "1474-4422",

publisher = "Lancet Publishing Group",

number = "10",

}

TY - JOUR

T1 - Secondary prevention of stroke

T2 - Can we do better than aspirin?

AU - Kumbhani, Dharam J.

AU - Bhatt, Deepak L.

N1 - Funding Information: DJK has no conflicts of interest. DLB has received institutional research support from AstraZeneca, Bristol-Myers Squibb, Eisai, Sanofi-Aventis, and The Medicines Company and has received honoraria from Duke Clinical Research Institute.

PY - 2010/10

Y1 - 2010/10

UR - http://www.scopus.com/inward/record.url?scp=77956876136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956876136&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(10)70217-9

DO - 10.1016/S1474-4422(10)70217-9

M3 - Letter

C2 - 20833590

AN - SCOPUS:77956876136

SN - 1474-4422

VL - 9

SP - 942

EP - 943

JO - The Lancet Neurology

JF - The Lancet Neurology

IS - 10

ER -

Secondary prevention of stroke: Can we do better than aspirin?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this